Beta blockers have mortality benefit in patients with HFrEF. Only Bisoprolol, Metoprolol succinate, Carvedilol, & Nebivolol have proven benefits in HFrEF. Carvedilol is a non selective beta blocker and Bisoprolol, Metoprolol, and Nebivolol are cardioselective beta blockers. All patients with HFrEF should be started on the beta blockers as soon as possible. However we need…

Read More “Beta Blockers in Heart Failure with Reduced Ejection Fraction (HFrEF)” »